Emerging role of monoclonal antibodies in the treatment of IgA nephropathy
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2023.2213800
Abstract: ABSTRACT Introduction IgA nephropathy is the most common primary glomerulonephritis worldwide. Immune complexes, composed of galactose-deficient IgA1 and Gd-IgA1 autoantibodies, are deposited in the mesangial area of the glomeruli where they induce complement-mediated inflammation. This… read more here.
Keywords: treatment iga; iga nephropathy; monoclonal antibodies; iga1 ... See more keywords
An update on the treatment of IgA nephropathy
Sign Up to like & getrecommendations! Published in 2017 at "Current Opinion in Nephrology and Hypertension"
DOI: 10.1097/mnh.0000000000000336
Abstract: Purpose of review The treatment of IgA nephropathy (IgAN) has been limited by several controversies in the literature, including the benefits of corticosteroids in addition to optimized renin–angiotensin system blockers (RASBs), in those with lower… read more here.
Keywords: risk adverse; risk; treatment iga; iga nephropathy ... See more keywords